BNP Paribas lowered shares of Sonova (OTCMKTS:SONVY - Free Report) from a strong-buy rating to a strong sell rating in a report published on Wednesday,Zacks.com reports.
Several other research analysts also recently commented on the company. Kepler Capital Markets upgraded Sonova from a "strong sell" rating to a "hold" rating in a research note on Friday, June 6th. HSBC downgraded Sonova from a "buy" rating to a "hold" rating in a research report on Wednesday, May 21st. Finally, Hsbc Global Res cut Sonova from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, May 21st. Three analysts have rated the stock with a sell rating and five have issued a hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Hold".
Check Out Our Latest Stock Analysis on Sonova
Sonova Stock Performance
Shares of OTCMKTS SONVY traded down $0.81 during trading on Wednesday, reaching $62.80. 43,715 shares of the stock traded hands, compared to its average volume of 21,572. The company has a quick ratio of 0.82, a current ratio of 1.21 and a debt-to-equity ratio of 0.61. The company has a 50-day moving average of $61.50 and a 200-day moving average of $63.70. Sonova has a 52-week low of $52.83 and a 52-week high of $77.56.
About Sonova
(
Get Free Report)
Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands.
Read More
Before you consider Sonova, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sonova wasn't on the list.
While Sonova currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
